Dana P Goldman
Dana P Goldman
Sol Price School of Public Policy, University of Southern California
Verified email at - Homepage
Cited by
Cited by
Participation of patients 65 years of age or older in cancer clinical trials
JH Lewis, ML Kilgore, DP Goldman, EL Trimble, R Kaplan, MJ Montello, ...
Journal of clinical oncology 21 (7), 1383-1389, 2003
Prescription drug cost sharing: associations with medication and medical utilization and spending and health
DP Goldman, GF Joyce, Y Zheng
Jama 298 (1), 61-69, 2007
Differences in life expectancy due to race and educational differences are widening, and many may not catch up
SJ Olshansky, T Antonucci, L Berkman, RH Binstock, A Boersch-Supan, ...
Health affairs 31 (8), 1803-1813, 2012
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study
MF Shapiro, SC Morton, DF McCaffrey, JW Senterfitt, JA Fleishman, ...
Jama 281 (24), 2305-2315, 1999
Pharmacy benefits and the use of drugs by the chronically ill
DP Goldman, GF Joyce, JJ Escarce, JE Pace, MD Solomon, M Laouri, ...
Jama 291 (19), 2344-2350, 2004
Can patient self-management help explain the SES health gradient?
DP Goldman, JP Smith
Proceedings of the National Academy of Sciences 99 (16), 10929-10934, 2002
The care of HIV-infected adults in the United States
SA Bozzette, SH Berry, N Duan, MR Frankel, AA Leibowitz, D Lefkowitz, ...
New England Journal of Medicine 339 (26), 1897-1904, 1998
Heterogeneity in healthy aging
DJ Lowsky, SJ Olshansky, J Bhattacharya, DP Goldman
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2014
Consumer demand and health effects of cost-sharing
DP Goldman, GF Joyce
The Oxford Handbook of the Economics of the Biopharmaceutical Industry, 365, 2012
Are the young becoming more disabled?
DN Lakdawalla, J Bhattacharya, DP Goldman
Health affairs 23 (1), 168-176, 2004
Substantial health and economic returns from delayed aging may warrant a new focus for medical research
DP Goldman, D Cutler, JW Rowe, PC Michaud, J Sullivan, D Peneva, ...
Health affairs 32 (10), 1698-1705, 2013
Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy
SA Bozzette, G Joyce, DF McCaffrey, AA Leibowitz, SC Morton, SH Berry, ...
New England Journal of Medicine 344 (11), 817-823, 2001
Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.
R Andersen, S Bozzette, M Shapiro, P St Clair, S Morton, S Crystal, ...
Health services research 35 (2), 389, 2000
Employer drug benefit plans and spending on prescription drugs
GF Joyce, JJ Escarce, MD Solomon, DP Goldman
Jama 288 (14), 1733-1739, 2002
Impact of oral nutritional supplementation on hospital outcomes.
TJ Philipson, JT Snider, DN Lakdawalla, B Stryckman, DP Goldman
The American journal of managed care 19 (2), 121-128, 2013
Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors
W Bruine de Bruin, HW Saw, DP Goldman
Journal of risk and uncertainty 61 (2), 177-194, 2020
Insulin Affordability: ADA Working Group Conclusions and Recommendations
M Bingham
Diabetes care 41, 1299-1311, 2018
Aging in America in the twenty‐first century: demographic forecasts from the MacArthur Foundation Research Network on an aging society
SJ Olshansky, DP Goldman, Y Zheng, JW Rowe
The Milbank Quarterly 87 (4), 842-862, 2009
Patient cost-sharing and healthcare spending growth
K Baicker, D Goldman
Journal of Economic Perspectives 25 (2), 47-68, 2011
Consequences Of Health Trends And Medical Innovation For The Future Elderly: When demographic trends temper the optimism of biomedical advances, how will tomorrow's elderly fare?
DP Goldman, B Shang, J Bhattacharya, AM Garber, M Hurd, GF Joyce, ...
Health Affairs 24 (Suppl2), W5-R5-W5-R17, 2005
The system can't perform the operation now. Try again later.
Articles 1–20